Drug Shortage Report for AURO-VALSARTAN HCT
Report ID | 99837 |
Drug Identification Number | 02408155 |
Brand name | AURO-VALSARTAN HCT |
Common or Proper name | Hydrochlorothiazide; valsartan |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE VALSARTAN |
Strength(s) | 25MG 320MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100s, 30 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-11-25 |
Estimated end date | 2021-02-19 |
Actual end date | 2021-02-18 |
Shortage status | Resolved |
Updated date | 2021-02-19 |
Company comments | Auro-Valsartan HCT 25mg/320mg (100's) available as of February 18, 2021 Auro-Valsartan HCT 25mg/320mg (30's) - Replaceable with Auro-Valsartan HCT 25mg/320mg (100's) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-11-27 | French | Compare |
v1 | 2019-11-27 | English | Compare |